Neurotechnology, a provider of deep-learning-based solutions and high-precision biometric identification and object recognition technologies, today announced that the company’s services and products, including the MegaMatcher Automatic Biometric Identification System (ABIS), were used for Ghana’s Biometric Voter Management System, providing voter registration, deduplication, adjudication, final voter list generation and verification during voting for the country’s general elections held on December 7, 2020.
Neurotechnology delivered the Biometric Voter Management System (Software) and provided related services for the Ghana Electoral Commission in record time – just nine months from start to finish – covering everything from initial voter registration to final voter list preparation and onsite support for the General Election.
Neurotechnology’s MegaMatcher ABIS provided deduplication for a total of 17,027,641 registrants who were eligible to vote in the general election. By matching fingerprints and/or facial biometrics for each registrant name, the system successfully identified 15,860 multiple registrations conducted by 7,890 unique individuals who attempted to register more than once using different names.
“We are highly satisfied with Neurotechnology’s software and services, which were provided in a short timeframe –nine months to be precise, from inception to completion,” stated Mrs. Jean Mensa, Chairperson for the Electoral Commission of Ghana. “The staff of Neurotech were highly professional and helpful. They were responsive and accessible in that they were physically present on site throughout the duration of the exercise.
By providing highly accurate identification and verification of each registered voter, and by ensuring that each voter was only able to cast one vote, the MegaMatcher ABIS Biometric Voter Management System helped to ensure fair, transparent, credible and successful general elections in Ghana.
“We were pleased to work with the Electoral Commission of Ghana for their Biometric Voter Management System,” said Irmantas Naujikas, Director of Neurotechnology.